LENZ Therapeutics, Inc. (LENZ)
6.50
-0.08 (1.22%)
Upcoming Events
Latest Headlines
LENZ Therapeutics Inc (LENZ) PT Lowered to $38 at H.C. Wainwright
May 12, 2026 6:50 AM - StreetInsider
LENZ Therapeutics Inc (LENZ) PT Lowered to $20 at Citi
May 12, 2026 5:23 AM - StreetInsider
Piper Sandler Downgrades LENZ Therapeutics Inc (LENZ) to Neutral
May 12, 2026 3:10 AM - StreetInsider
LENZ Therapeutics, Inc. (LENZ) Misses Q1 EPS by 132c
May 11, 2026 4:32 PM - StreetInsider
Form 10-Q LENZ Therapeutics, Inc. For: Mar 31
May 11, 2026 4:11 PM - SEC Filing
Form 8-K LENZ Therapeutics, Inc. For: May 11
May 11, 2026 4:09 PM - SEC Filing
Form ARS LENZ Therapeutics, Inc. For: Dec 31
April 28, 2026 4:45 PM - SEC Filing
Form DEFA14A LENZ Therapeutics, Inc.
April 28, 2026 4:43 PM - SEC Filing
Form DEF 14A LENZ Therapeutics, Inc. For: Jun 12
April 28, 2026 4:40 PM - SEC Filing
Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: BlackRock, Inc.
April 27, 2026 4:14 PM - SEC Filing
LENZ Therapeutics Inc (LENZ) PT Lowered to $48 at H.C. Wainwright
April 21, 2026 6:40 AM - StreetInsider
LENZ submits UK marketing application for presbyopia treatment
April 20, 2026 8:04 AM - StreetInsider
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdo
April 20, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: Squarepoint Ops LLC
April 8, 2026 3:07 PM - SEC Filing
Form 4 LENZ Therapeutics, Inc. For: Mar 27 Filed by: George Jeffrey P.
March 30, 2026 8:47 AM - SEC Filing
Form 4 LENZ Therapeutics, Inc. For: Mar 27 Filed by: Chevallard Daniel R.
March 30, 2026 8:47 AM - SEC Filing
Form 4 LENZ Therapeutics, Inc. For: Mar 27 Filed by: Schimmelpennink Evert B.
March 30, 2026 8:47 AM - SEC Filing
LENZ Therapeutics Inc (LENZ) PT Lowered to $26 at Citi
March 25, 2026 7:08 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on LENZ Therapeutics Inc (LENZ)
March 25, 2026 6:58 AM - StreetInsider
Form S-8 LENZ Therapeutics, Inc.
March 24, 2026 4:28 PM - SEC Filing
LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 116c
March 24, 2026 4:19 PM - StreetInsider
Form 10-K LENZ Therapeutics, Inc. For: Dec 31
March 24, 2026 4:10 PM - SEC Filing
LENZ Therapeutics Inc (LENZ) PT Lowered to $29 at BofA Securities
March 24, 2026 3:58 PM - StreetInsider
LENZ Therapeutics Inc (LENZ) PT Lowered to $39 at Piper Sandler
March 24, 2026 1:01 PM - StreetInsider
Form 8-K LENZ Therapeutics, Inc. For: Mar 24
March 24, 2026 8:12 AM - SEC Filing
Full Article List
